Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Paricalcitol vs Zemplar in Healthy Subjects
NCT02322632Phase 1Completed
- Sponsor
- Dr. Reddy's Laboratories
- Start
- Nov 2010
- Primary completion
- Dec 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of paricalcitol in secondary hyperparathyroidism (SHPT) (2 arms), sponsored by Dr. Reddy's Laboratories. Primary endpoint: Area Under Curve. Started Nov 2010; status: completed.
02
Drugs
paricalcitol
03
Conditions
secondary hyperparathyroidism (SHPT)
Beyond the preview
Go deeper on NCT02322632.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02322632.